97798-49-7

Upstream product

• 70987-78-9 (S)-Glycidyl tosylate 
• 108-98-5 thiophenol 
• 113826-06-5 (R)-glycidyl tosylate 
• 97798-48-6 (S)-(2,3-dihydroxypropyl) phenyl sulfide 
• 98-59-9 p-toluenesulfonyl chloride 
• 97798-47-5 1-hydroxy-3-phenylthio-2-propanone 
• 22198-57-8 acetate of 1-hydroxy-3-phenylthio-2-propanone 

Downstream Products

• 97798-51-1 (S)-5-Phenyl-1-phenylsulfanyl-pentan-2-ol 
• 97859-56-8 (S)-1-Phenylsulfanyl-tridecan-2-ol 
• 67210-33-7 (S)-(+)-1-(benzenesulfanyl)-2-butanol 
• 97798-50-0 (S)-1,2-epoxy-3-(phenylthio)propane 

Relevant academic research and scientific papers

Aminoalcohol derivatives and their use as beta 3 adrenergic agonists

This invention relates to new aminoalcohol derivatives or salts thereof represented by the following formula [I]: wherein each symbol is as defined in the specification or salts thereof which have gut selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence and anti-pollakiuria activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment diseases indicated in the specification to a human being or an animal.

OPTICALLY PURE (S)-3-PHENYLTHIO-1,2-PROPANEDIOL: SYNTHESIS BY THE YEAST REDUCTION AND USE AS A PRECURSOR OF BOTH ENANTIOMERS OF SECONDARY ALCOHOLS

Optically pure (S)-3-phenylthio-1,2-propanediol was obtained by the enantioselective reduction of 1-hydroxy-3-phenylthio-2-propanone with the Baker's yeast, and was found to be a convenient precursor for both enantiomers of secondary alcohols, which was d